Islam F, Urade Y, Watanabe Y, Hayaishi O
Hayaishi Bioinformation Transfer Project, Research Development Corporation of Japan, Osaka.
Arch Biochem Biophys. 1990 Mar;277(2):290-5. doi: 10.1016/0003-9861(90)90581-i.
A solid phase, particle concentration fluorescence immunoassay (PCFIA) was developed for the measurement of prostaglandin (PG) D synthase in the 100,000g supernatant of various regions of the rat central nervous system. In this assay, the enzyme (in the range of 1-25 micrograms protein of brain supernatant or 1-100 ng of the purified enzyme) is attached to submicrometer carboxypolystyrene beads coated with polyclonal anti-rat brain PGD synthase IgG. The total particle-bound enzyme is assayed with fluorescein isothiocyanate (FITC)-conjugated monoclonal anti-PGD synthase IgG after incubation for 1 h. The optimum assay condition was obtained when carboxyl particles coated with ca. 500 micrograms/ml of polyclonal IgG at pH 5.0 and 5 micrograms/ml of FITC-IgG were used. No significant fluorescence was observed when FITC conjugates or carboxyl particles were prepared using IgG from nonimmunized rabbits. Heat treatment of the brain supernatant decreased the specific binding of the enzyme in parallel with the loss of enzyme activity, indicating that the denatured enzyme is not recognized by this assay method. The PGD synthase immunoreactivity was widely distributed in the brain regions and was highest in the paraflocculus. Although slight discrepancy was observed between the concentration by PCFIA and the enzyme activity measured by using [14C]PGH2 in some brain regions, there is a considerable correlation (0.727) between the values by both methods in the same brain regions. The PCFIA now developed showed higher sensitivity (around 10 times), greater reliability, and larger number of samples measurable at once than the radio-TLC assay using [14C]PGH2. This method could provide valuable information concerning the regulatory mechanisms of PGD synthase.
为测定大鼠中枢神经系统不同区域100,000g上清液中的前列腺素(PG)D合酶,开发了一种固相颗粒浓度荧光免疫分析(PCFIA)方法。在该分析中,酶(脑上清液中蛋白质含量为1 - 25微克或纯化酶为1 - 100纳克)附着于包被有抗大鼠脑PGD合酶IgG多克隆抗体的亚微米级羧基聚苯乙烯珠上。孵育1小时后,用异硫氰酸荧光素(FITC)偶联的抗PGD合酶IgG单克隆抗体测定与颗粒结合的总酶量。当使用在pH 5.0时包被有约500微克/毫升多克隆IgG和5微克/毫升FITC - IgG的羧基颗粒时,可获得最佳分析条件。使用未免疫兔的IgG制备FITC偶联物或羧基颗粒时,未观察到明显荧光。脑上清液经热处理后,酶的特异性结合减少,同时酶活性丧失,这表明该分析方法无法识别变性酶。PGD合酶免疫反应性在脑区广泛分布,在小脑旁小叶中最高。尽管在某些脑区,PCFIA测定的浓度与使用[14C]PGH2测定的酶活性之间存在轻微差异,但同一脑区两种方法测定的值之间存在显著相关性(0.727)。目前开发的PCFIA与使用[14C]PGH2的放射性薄层色谱分析相比,灵敏度更高(约高10倍)、可靠性更强,且可同时检测的样本数量更多。该方法可为PGD合酶的调节机制提供有价值的信息。